Gene · 406993
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The long and short: Non-coding RNAs in the mammalian inner ear. | Hear Res | 2023 | 36566643 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR-211-5p/CREB5 axis. | Cancer Med | 2023 | 36565037 | PubTator, text mining | PubMed |
| Molecular signaling network and therapeutic developments in breast cancer brain metastasis. | Adv Cancer Biol Metastasis | 2023 | 36536947 | PubTator, text mining | PubMed |
| Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. | Cancer Commun (Lond) | 2023 | 36424360 | PubTator, text mining | PubMed |
| Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis. | Noncoding RNA Res | 2023 | 36311994 | PubTator, text mining | PubMed |
| MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer. | Cell Signal | 2023 | 36309329 | PubTator, text mining | PubMed |
| TGF-β1 regulates the lncRNA transcriptome of ovarian granulosa cells in a transcription activity-dependent manner. | Cell Prolif | 2023 | 36125095 | PubTator, text mining | PubMed |
| Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis. | Cancer Med | 2023 | 36057947 | PubTator, text mining | PubMed |
| LncRNA MCM3AP-AS1 serves as a competing endogenous RNA of miR-218 to upregulate GLUT1 in papillary thyroid carcinoma. | Arch Endocrinol Metab | 2023 | 35929906 | PubTator, text mining | PubMed |
| Development of Ferroptosis-Associated ceRNA Network in Periodontitis. | Int Dent J | 2023 | 35810010 | PubTator, text mining | PubMed |
| Common microRNAs in Epilepsy and Migraine: Their Possibility as Candidates for Biomarkers and Therapeutic Targets during Comorbid Onset of Both Conditions. | CNS Neurol Disord Drug Targets | 2023 | 35473539 | PubTator, text mining | PubMed |
| Differential Expression and in Silico Functional Analysis of Plasma MicroRNAs in the Pathogenesis of Non-segmental Vitiligo. | Indian J Dermatol | 2022 | 36998849 | PubTator, text mining | PubMed |
| On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications. | Front Oncol | 2022 | 36844925 | PubTator, text mining | PubMed |
| Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis. | Front Cell Dev Biol | 2022 | 36704194 | PubTator, text mining | PubMed |
| CircCCDC66: Emerging roles and potential clinical values in malignant tumors. | Front Oncol | 2022 | 36698408 | PubTator, text mining | PubMed |
| MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression. | Front Cell Dev Biol | 2022 | 36619870 | PubTator, text mining | PubMed |
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
| Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment. | Cancers (Basel) | 2022 | 36612077 | PubTator, text mining | PubMed |
| MicroRNAs and long non-coding RNAs in cartilage homeostasis and osteoarthritis. | Front Cell Dev Biol | 2022 | 36582467 | PubTator, text mining | PubMed |
| Overexpression of microRNA-211 in Functional Dyspepsia via Downregulation of the Glial Cell Line-Derived Neurotrophic Factor (GDNF) by Increasing Phosphorylation of p38 MAPK Pathway. | Can J Gastroenterol Hepatol | 2022 | 36569394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406993/papers?page=11